Clinical trial design requires inclusion criteria that patients be on optimal medical therapy prior to enrollment or randomization, meaning that they are on medical regimens proven to be safe and effective and considered a standard in clinical practice for the particular disease state being studied. Only then can any clinical or statistical significance be determined between study groups. This chapter outlines optimal medical therapies for hypertension, acute coronary syndrome, myocardial infarction, heart failure, and/or arrhythmias. © 2009 Humana Press.
CITATION STYLE
Dopp, A. L., & Sims, J. J. (2005). Pharmacotherapy for cardiac diseases. In Handbook of Cardiac Anatomy, Physiology, and Devices: Second Edition (pp. 383–392). Humana Press. https://doi.org/10.1007/978-1-60327-372-5_24
Mendeley helps you to discover research relevant for your work.